Bay
Area POCC Group Spring Meeting Recap!
Meeting host Tina Sherwin
from John Muir Health, welcomed over 30 attendees to the
Spring meeting of the Bay Area POCC Group on Friday, May 11
in Concord, CA.
The group heard 4
presentations from outstanding speakers, earned multiple
CEUs, and it was a very interactive day. To view the slides
from each presenter, click on the appropriate link below.
We also want to thank Roche for
sponsoring and providing a great lunch.
We
are also looking for a host for our 2018 Fall/Winter
meeting.
It's easier than you think and you'll
have plenty of help and support. If you're willing and
interested, contact
Robyn Medeiros.
“Its CLIA-waived
so nothing can go wrong, right?”
Our
first speaker was Norman Moore,
PhD, Alere Director of Scientific Affairs,
Infectious Diseases, who presented “Its CLIA-waived
so nothing can go wrong, right?”.
Dr. Moore's talk focused
on medical errors being the 3rd leading cause of death in
the U.S. the 3 leading causes of deaths and some of the
reasons why that is. He also covered changes in medical
testing; clinical sampling, cheek and saliva swab testing;
pregnancy, influenza, RSV, HIV; and Strep A testing.
To view this
presentation, click on the image ...
“Importance of
Evidence Based Medicine in POCT”
Dr.
Moore was also our second speaker, when he spoke on “Importance of
Evidence Based Medicine in POCT”.
Infectious
diseases are a significant killer in the United States with
many people fearing the rise of antibiotic resistant
microorganisms as one of the greatest global health threats
we face.
The miracle of the antibiotic age is waning and we must do
what we can do to specifically identify the pathogens
causing disease and treat them appropriately, either with
the appropriate antibiotic – or no antibiotic if it is a
viral disease.
Depending
upon the clinical disease, specific antibiotics can be more
effective with less adverse affects than broad spectrum
compounds.
To view this
presentation, click on the image ...
“The 1,2,3’s of ACT
testing"
Our
next speaker was
Marcia Zucker,
PhD, sponsored by Abbott
POC/i-STAT, who lead a discussion on “The 1,2,3’s of ACT
testing".
Briefly, Dr. Zucker told
the group that ACTs are Global Assays; they are used to
monitor heparin and that heparin is non-homogenous; that
heparin differs by manufacturer & lot; and that ACTs differ
by manufacturer, activator and detection mechanism.
To view this
presentation, click on the image ...
“A Diagnostic
Approach to Pleural Effusion”
The
day's final speaker was
Christine Arruda, from Siemens Healthcare Diagnostics
Inc. who presented “A Diagnostic
Approach to Pleural Effusion”.
The objectives of this
talk were to define the leading causes of pleural effusion;
classify the type of effusion; and identify procedures and
tests associated with diagnosis.
To view this
presentation, click on the image ...
|